Professur für Innere Medizin (Nephrologie)

Individualised treatment targets in patients with type-2 diabetes and hypertension (2018) Schmieder R, Tschoepe D, Koch C, Ouarrak T, Gitt AK Journal article Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up (2018) Jung S, Ott C, Karg MV, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder R Journal article Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success (2018) Saxena M, Shour T, Shah M, Wolff CB, Julu PO, Kapil V, Collier DJ, et al. Journal article Retinal capillary and arteriolar changes in patients with chronic kidney disease (2018) Bosch A, Scheppach JB, Harazny JM, Raff U, Schmieder R, Schneider M, Eckardt KU Journal article Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension (2018) Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder R Journal article European Society of Hypertension position paper on renal denervation 2018 (2018) Schmieder R, Mahfoud F, Azizi M, Pathak A, Dimitriadis K, Kroon AA, Ott C, et al. Journal article Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials (2018) Boehm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, Mancia G, et al. Journal article Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) Azizi M, Schmieder R, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, et al. Journal article A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs (2018) Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, et al. Journal article SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial (2018) Karg M, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, et al. Journal article